TAF(Tenofovir Alafenamide Hemifumarate)
Tenofovir alafenamide is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic hepatitis B virus infection (HBV) in adults and children 12 years of age and older who meet certain requirements, as determined by a health care provider.
| Catalog Number | API1392275567 |
| Alternative Name(s) | Tenofovir Alafenamide fumarate GS-7340 Hemifumarate Vemlidy tenofovir alafenamide hemifumarate |
| Research Area | Antivirus APIs |
| Molecular Formula | C46H62N12O14P2 |
| CAS# | 1392275-56-7 |
| SMILES | CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3.CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3.C(=CC(=O)O)C(=O)O |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/taftenofovir-alafenamide-hemifumarate-item-6155.html |